Global Human Fibrin Glue Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Human Fibrin Glue Market Research Report 2024
Human Fibrin Glue is a surgical formulation used to create a fibrin clot for hemostasis, cartilage repair surgeries or wound healing. It contains separately packaged human fibrinogen and human thrombin. Human fibrin glues are involved in the process of haemostasis and wound healing. A Human Fibrin Glue (HFG) is made of two components contained in separate vialsa freeze-dried concentrate of clotting proteins, mainly fibrinogen, Factor XIII and fibronectin (the sealant), and freeze-dried thrombin (the catalyst), which is applied to a wound or during the surgery to avoid blood loss, create a clot for haemostasis, decrease the hospital stay with lesser scars.
According to Mr Accuracy reports’s new survey, global Human Fibrin Glue market is projected to reach US$ 889.1 million in 2034, increasing from US$ 492 million in 2024, with the CAGR of 8.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Fibrin Glue market research.
Key manufacturers engaged in the Human Fibrin Glue industry include Grifols, Baxter, OMRIX Biopharmaceuticals, Johnson & Johnson(Ethicon), CSL Limited, Shanghai RAAS, Corza Health, Hualan Biological and Shanghai Xinxing MEDICINE Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Human Fibrin Glue were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Human Fibrin Glue market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Fibrin Glue market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Grifols
Baxter
OMRIX Biopharmaceuticals
Johnson & Johnson(Ethicon)
CSL Limited
Shanghai RAAS
Corza Health
Hualan Biological
Shanghai Xinxing MEDICINE Co., Ltd.
Segment by Type
Liquid
Patch
Hospital
Clinic
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Fibrin Glue report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Human Fibrin Glue market is projected to reach US$ 889.1 million in 2034, increasing from US$ 492 million in 2024, with the CAGR of 8.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Fibrin Glue market research.
Key manufacturers engaged in the Human Fibrin Glue industry include Grifols, Baxter, OMRIX Biopharmaceuticals, Johnson & Johnson(Ethicon), CSL Limited, Shanghai RAAS, Corza Health, Hualan Biological and Shanghai Xinxing MEDICINE Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Human Fibrin Glue were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Human Fibrin Glue market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Fibrin Glue market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grifols
Baxter
OMRIX Biopharmaceuticals
Johnson & Johnson(Ethicon)
CSL Limited
Shanghai RAAS
Corza Health
Hualan Biological
Shanghai Xinxing MEDICINE Co., Ltd.
Segment by Type
Liquid
Patch
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Fibrin Glue report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices